jueves, 17 de junio de 2021

Novel ferritin nanoparticle vaccine candidate effective against SARS-CoV-2 variants in preclinical trials

Novel ferritin nanoparticle vaccine candidate effective against SARS-CoV-2 variants in preclinical trials

No hay comentarios:

Publicar un comentario